Filter Results:
(621)
Show Results For
- All HBS Web
(621)
- People (2)
- News (57)
- Research (447)
- Events (2)
- Multimedia (9)
- Faculty Publications (391)
Show Results For
- All HBS Web
(621)
- People (2)
- News (57)
- Research (447)
- Events (2)
- Multimedia (9)
- Faculty Publications (391)
- 12 Dec 2023
- Blog Post
Bridging Science and Business: My Summer Internship at Eli Lilly
planning. As summer gives way to fall, I can't help but reflect on the incredible journey that this internship has been—a journey not undertaken in isolation but as part of the vibrant, inquisitive community that comprises the MS/MBA View Details
Stefan H. Thomke
Stefan Thomke (sthomke@hbs.edu), an authority on the management of innovation, is the William Barclay Harding Professor of Business Administration at Harvard Business School. He has worked with firms on product, process, and... View Details
Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
- October 2022 (Revised May 2023)
- Case
Ginkgo Bioworks vs. Scorpion Capital: The Debate Over Related-Party Revenues
Ginkgo Bioworks, a synthetic biology company based in Boston, Massachusetts, faced divergent views on its revenue possibilities and accounting practices. After a report emerged accusing it of fraudulent accounting and lack of innovation, its share price plunged. But... View Details
Keywords: Fraud Allegations; Revenue; Reports; Accounting Audits; Innovation and Management; Investment; Biotechnology Industry; Boston
Dey, Aiyesha, Jonas Heese, Suraj Srinivasan, and Annelena Lobb. "Ginkgo Bioworks vs. Scorpion Capital: The Debate Over Related-Party Revenues." Harvard Business School Case 123-037, October 2022. (Revised May 2023.)
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
personalized oncology care. They have collectively raised more than $500M in funding and an additional $244M from an IPO in June 2020. The fellowship is guided by Peter Barrett, executive fellow, and a Key Advisory Board of 13 seasoned business and View Details
Justine Boudou
Justine Boudou is a doctoral student in the Technology and Operations Management (TOM) unit at Harvard Business School.
She is primarily interested in the economics of science and innovation. Justine holds a MSc from the engineering school... View Details
Dafna Bearson
Dafna Bearson is a doctoral candidate in the Strategy Unit at Harvard Business School. Her research interests lie at the intersection of strategy and innovation. Specifically, her research focuses on intellectual property commercialization strategy in startups... View Details
Gerald Zaltman
*Joined Harvard Faculty: 1991
Prior Faculty Appointments: Northwestern University, 1968-75;
University of Pittsburgh, 1975-91
Prior Faculty Appointments: Northwestern University, 1968-75;
University of Pittsburgh, 1975-91
*Doctoral Degree in Sociology Received from: The John Hopkins University;
MBA Degree Received from: The University of... View Details
- Web
Pagliuca Harvard Life Lab | About
become a life sciences cluster and their understanding of the need for lab space to support Boston as a hub for biotechnology ventures,” said Harvard Business School Dean Nitin Nohria. Harvard President Drew Faust added, “The Life Lab is... View Details
David A. Thomas
David Thomas is H. Naylor Fitzhugh Professor of Business Administration at Harvard Business School. His research addresses issues related to executive development, cultural diversity in organizations, leadership and organizational change. He recently served as a... View Details
- Web
For Recruiters - Health Care
systems, e-health firms, pharmaceutical companies, medical device manufacturers, and biotechnology companies. Hire a Summer Intern Summer internships are valuable for both employers and students as a “test run.” Employers benefit most... View Details
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
Kyle Schirmann
Kyle Schirmann is a doctoral student in the Strategy unit at Harvard Business School. His primary interests are science-based innovation in the Global South and the creative and cultural industries. Before joining HBS, Kyle worked as a software engineer at Bloomberg... View Details
- 09 Mar 2023
- Blog Post
African American Student Union Spotlight on Joint Degrees
scaling its impact. This led me to seek out opportunities that would allow me to integrate my knowledge of technology, life sciences, and business. When I learned about the MS/MBA joint degree programs in Engineering Science and View Details
John T. Gourville
John Gourville is the Albert J. Weatherhead, Jr. Professor of Business Administration at the Harvard Business School. He joined the HBS Marketing Unit in 1995 after receiving his Ph.D. at the University of Chicago in marketing and behavioral research. His most... View Details
Joey Ryu
Joey (Won Jung) Ryu is a doctoral student in the Strategy unit at Harvard Business School. Her primary interests are strategic management, economics of innovation and entrepreneurship. Prior to joining HBS, Joey received her master's degree from Cornell University... View Details
- Web
Advisory Board - Entrepreneurship
investments in over fifty companies, primarily in the biotechnology and communications equipment areas, including Human Genome Sciences, Millennium Pharmaceuticals, Vertex Pharmaceuticals, Appex, Brooktrout Technologies, and Cascade... View Details
- Profile
Prineeta Kulkarni
Prineeta Kulkarni originally "dreamed of becoming a scientist." She completed a dual biotechnology BS/MS at the University of Pune, but when it came time to launch her career, she shifted direction. "I wanted to see the... View Details
- Web
Winners & Runners-Up | New Venture Competition
of biotechnology by revolutionizing the water treatment industry with our patented, low cost, environmentally friendly process for water demineralization. Elective Medical Lending Boyd Bishop Simon Mattox Business Track Runner-Up Elective... View Details
- September 2010 (Revised July 2013)
- Case
Alnylam Pharmaceuticals: Building Value from the IP Estate
By: Willy C. Shih and Sen Chai
The learning objective of this case is to help students recognize the interplay between intellectual property (IP) rights and corporate strategy. We do this by examining what is a fairly atypical circumstance today in which a single firm is able to secure what it... View Details
Keywords: Patents; Lawsuits and Litigation; Rights; Competitive Strategy; Corporate Strategy; Biotechnology Industry; Biotechnology Industry; United States
Shih, Willy C., and Sen Chai. "Alnylam Pharmaceuticals: Building Value from the IP Estate." Harvard Business School Case 611-009, September 2010. (Revised July 2013.)
- 27 May 2022
- Blog Post
Q&A with the HBS Armed Forces Alumni Association, MBA Class of 2023
attend. They have insight into how to approach the application process. Kristin Wihera (MS/MBA Biotechnology 2023) Hometown: Littleton, CO Undergraduate university and major: Boston University; Human Physiology Military experience: Navy... View Details